• Maintenance treatment of bronchospasm, including chronic bronchitis, COPD and emphysema:
    • 5mg nebulized every 6-8 hours
  • Acute asthma exacerbations (Off-label):
    • Adults and > years:5mg nebulized every 20 min *3 doses then PRN
    • <6 years: 25mg nebulized every 20 min *3 doses then PRN
    • 6-12 years:25-0.5mg nebulized every 20 min *3 doses then PRN

Inhalation solution: 0.25mg/2mL

Avoid getting in eyes. Flush immediately with water if it gets in the eyes

Anticholinergic

It prevents increase in intracellular calcium concentration that is caused by interaction of acetylcholine with muscarinic receptors on bronchial smooth muscle

  • Cough
  • Nervousness
  • Nausea
  • Xerostomia
  • Dyspepsia
  • Dizziness
  • Headache
  • COPD exacerbation
  • Oral irritation
  • Rash
  • Urticaria
  • Hypersensitivity to ipratropium, atropine or derivatives

None restricted

                          Drug Status

Availability Prescription only
Pregnancy Category B
Breastfeeding Safe to use
Schedule Not controlled
BRAND NAME STRENGTH FORMULATION PACK SIZE MANUFACTURER DISTRIBUTOR
Atrovent UDV 0.25mg/2mL Nebuliser Solution 20D Boehringer Ingelheim Surgipharm Ltd
Atrovent UDV 0.5mg/2mL Nebuliser Solution 20D Boehringer Ingelheim Surgipharm Ltd
Atrovent 20mcg Inhalation 200D Boehringer Ingelheim Surgipharm Ltd